ArticleDermatology and therapy2023

Correction to: Matching-Adjusted Indirect Comparison of the Long-Term Efficacy of Deucravacitinib Versus Adalimumab for Moderate to Severe Plaque Psoriasis.

April W Armstrong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.